Delivery Order SPE2DR25D1053-SPE2DR26FV858
- Not listed
- The Defense Logistics Agency (DLA) awarded a $5,256.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Prevymis 480 mg tablets (7-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of February 10, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used primarily in immunocompromised patients,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Prevymis 480 mg tablets in a seven-count package configuration. This firm fixed-price delivery order, valued at $9,946.92, represents a non-competitive award and is scheduled for completion by November 28, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Prevymis 480 mg tablets (7-count packages) under a firm fixed-price contract valued at $4,719.34, with completion scheduled for October 6, 2025. This competitively awarded, non-set-aside delivery order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used primarily in immunocompromised...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Prevymis 480 mg tablets (7-count) with a ceiling value of $9,438.70. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is set for ultimate completion by October 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication...
- The Defense Logistics Agency awarded a delivery order valued at $5,256.05 to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (7-count units) on January 22, 2026, with an ultimate completion date of February 12, 2026. This is a firm fixed-price, non-set-aside contract with performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite...
- The Defense Logistics Agency awarded a $4,719.34 firm fixed price delivery order to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (quantity 7) on June 18, 2025, with an ultimate completion date of July 11, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used to prevent cytomegalovirus infection in immunocompromised patients, representing part of the Defense...
- The Defense Logistics Agency awarded a $4,973.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets (7-count units) on October 27, 2025, with completion targeted for November 18, 2025. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Prevymis 480 mg tablets in a quantity of seven units, with a contract ceiling value of $4,719.34 and an ultimate completion date of October 7, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Prevymis is an...
- The U.S. Defense Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Prevymis 480 mg tablets in quantities of seven tablets, valued at $4,719.34. The delivery order, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a non-competitive award under the company's existing contract vehicle. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. Prevymis...
- The Defense Logistics Agency awarded a delivery order valued at $4,973.46 to AmerisourceBergen Drug Corp for Prevymis 480 mg tablets (quantity 7) on December 1, 2025. This non-set-aside, firm fixed price delivery order is scheduled for completion by December 22, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used primarily for cytomegalovirus prophylaxis in immunocompromised patients, supporting the federal...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV858Delivery Order
The Defense Logistics Agency awarded a $5,256.05 delivery order to AmerisourceBergen Drug Corp for 480 mg Prevymis tablets (seven-count packages) on January 28, 2026, with a completion date of February 19, 2026. This firm fixed-price contract is non-set-aside and was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Prevymis is an antiviral medication used primarily in immunocompromised populations, particularly transplant patients, reflecting the Defense Logistics Agency's role in supplying pharmaceutical products for military healthcare systems. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.999 billion vehicle valued through December 2031 that enables comprehensive global pharmaceutical support across multiple therapeutic domains. The IDC serves as a prime vendor contract supporting military treatment facilities, veterans' healthcare programs, and other federal medical institutions with brand-name and generic medications, vaccines, and specialized medical supplies. AmerisourceBergen's extensive federal contracting history demonstrates its established capability to fulfill government medical procurement requirements through open competition, with this particular task order representing a modest-value pharmaceutical delivery within a significantly larger contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 1/27/26 |